G-Tube Rapid Reinsertion Tray


The global enteral feeding devices market was valued at US 2.41 billion in 2018 and is expected to grow at a Compound Annual Growth Rate (CAGR) of 5.89% during the forecast period of 2019-2025.

Unmet medical needs in emerging markets such as Brazil, India, and China, as well as the Middle East and Africa and the introduction of new products enabled with technological advancements are expected to serve this market as future growth opportunities.

As far as market share, the North American enteral feeding devices market held the majority of the market share in 2018 at nearly 36%, owing to the presence of a sophisticated health care infrastructure in this region coupled with high patient awareness levels and rising per capita health care expenditures. Europe held the next largest share of the market in 2018 at approximately 32%. However, the Asia-Pacific enteral feeding devices market with a present market share of 27% is expected to grow at the fastest CAGR of 6.8% from 2019-2025, owing to drivers such as the presence of high unmet medical needs in emerging markets with constantly improving healthcare infrastructure and healthcare expenditures in countries such as India and China. Other factors include a rise in the number of hospital admissions, geriatric populations, number of malnutrition patients, and an increasing prevalence of lifestyle diseases and other disorders such as diabetes, autism and cancer.

Additional key market drivers of enteral feeding devices include an increasing rate of premature births, growing prevalence of global neonatal mortality rates, an increase in prevalence of patients with digestive complications as well as a growing demand for home healthcare as a cost effective alternative to hospital based treatment.

Product innovation, development of technological advancements and the entry into emerging Asian and Latin American markets in an attempt to capitalize on the untapped opportunities are two of the primary growth and sustainability strategies adopted by the market players. Abbott Nutrition dominated the market in terms of revenue share in 2018 at over 30%.

Enteral nutrition is considered reasonable and necessary for a patient with a functioning gastrointestinal tract who due to pathology to, or non-functioning of the structures that normally permit food to reach the digestive tract, cannot maintain weight and strength commensurate with his or her general condition.

Enteral feeding should be incorporated into routine clinical care for specific patient populations such as patients with head injury, stroke, or motor neuron disease, also one who experiences severe dysphagia or swallowing related difficulties. It may also be indicated in patients with severe pancreatitis, dementia, Alzheimer’s disease, pulmonary disease, liver disease, short bowel syndrome, inflammatory bowel disease, oral and neck cancers, esophageal cancer, large burns, significant trauma as well as sepsis.

Patients typically receive this nutritional support therapy for less than six weeks, although some patients may rely on enteral nutrition throughout their lives., Enteral nutrition is administered in all healthcare settings, including home care, long-term care and acute care settings to a diverse patient population.

In a 2007 study approximately 250,000 patients received enteral nutrition during their US hospital stay. Also, approximately 200,000 Percutaneous Endoscopic Gastronomy (PEG) tubes were placed with a projection of approximately 400,000 PEG tube placements by 2020 annually. At present there are approximately 2,000,000 adult tube feeding recipients in the US, not including hospitalized patients, new PEG tube placements, nursing home patients as well as home healthcare patients. With a progressive increase in the aging population of baby boomers, these numbers will only increase over time, further establishing the need and usefulness of the G-tube Rapid Reinsertion Tray to continue to assist in maintaining a healthy aging population that may require enteral nutrition.

According to the U.S. Census Bureau, the total population aged above 65 years was 181.6 million in 2011 and is expected to reach 244.7 million by 2019. Thus aging populations is one of the major drivers of the enteral feeding device market. Also with the the global percentage of the population over the age of 65 years expected to grow from 7% in 2000 to 16% by 205, enteral feeding devices are expected to witness increased penetration over the forecast period.

In the pediatric population, G-tube placement is one of the most common operations performed in children for a variety of reasons including cystic fibrosis, prematurity, metabolic and genetic abnormalities as well as neurologic, cardiac and oropharyngeal problems. G-tubes in children comprise 5% of all G-tubes placed in the United States. It has been noted that the G-tube exchange process in pediatric patients has shown a potential for major complications to take place including stomal disruption, bowel obstruction, or peritonitis. The most common complaint concerning pediatric G-tubes in the Emergency Department has been dislodgement. 

The G-tube Rapid Reinsertion Tray allows for rapid reinsertion at the bedside thereby reducing the time the tube is removed from the stoma tract eliminating the possibility of collapse of the tissue walls and the stoma tract. It also reduces the costs associated with reinserting the tube due to accidental extrusion, a leaking tube, blocked tube, peri-stomal infection, tubal fungal colonization as well as routine exchange after extended use. The rapid reinsertion also eliminates the need for hospital admission, endoscopic or surgical extended use. The rapid reinsertion also eliminates the need for hospital admission, endoscopic or surgical intervention, anesthesia and subsequent post-op care as well as the likelihood of readmission to a healthcare facility after discharge. The more rapidly the G-tube is reinserted the less likely the patient will missing nutritional intervention which decreases the risk of sepsis and intra-abdominal abscesses, as well as pneumonia and weight loss, pressure ulcers and urinary tract infections. The G-tube Rapid Reinsertion Tray not only contributes to the general health and well-being of the patient by allowing continuous nutrition and decreasing the likelihood of infections, but also reduces soaring medical care costs in both the United States and worldwide. The G-tube Rapid Reinsertion Tray gas parent coverage in the US, the European Union, India and Japan. The population of these countries includes approximately 3.1 billion people, over 60,000 hospitals, numerous nursing homes, urgent care centers, home health care services, as well as United States VA hospitals and clinics at home and abroad.